Testing effectiveness (Phase 2)Study completedNCT00109967
What this trial is testing
CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Who this might be right for
Recurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 71